Home Biosimilar Antibodies Immunology & Inflammation CD markers Belimumab (Anti-TNFSF13B / BAFF / CD257) For research use only.
Not for use in humans.

Belimumab (Anti-TNFSF13B / BAFF / CD257)

Synonyms: Benlysta, LymphoStat B

Belimumab (Anti-TNFSF13B / BAFF / CD257) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research. MW : 144.56 kDa.

Belimumab (Anti-TNFSF13B / BAFF / CD257)

Click to purchase the isotype control of Belimumab (Anti-TNFSF13B / BAFF / CD257)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 13.64mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Belimumab (Anti-TNFSF13B / BAFF / CD257) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research. MW : 144.56 kDa.

Product Details

CAS No. 356547-88-1
Molecular Weight 144.56 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Belimumab (Anti-TNFSF13B / BAFF / CD257) | Belimumab (Anti-TNFSF13B / BAFF / CD257) supplier | purchase Belimumab (Anti-TNFSF13B / BAFF / CD257) | Belimumab (Anti-TNFSF13B / BAFF / CD257) cost | Belimumab (Anti-TNFSF13B / BAFF / CD257) manufacturer | order Belimumab (Anti-TNFSF13B / BAFF / CD257) | Belimumab (Anti-TNFSF13B / BAFF / CD257) distributor